Pediatrix Medical Group, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Pediatrix Medical Group, Inc. (MD) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$99.07 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2025-02-20
- Pediatrix Medical Group, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was -$124.29M, a 617.86% decline year-over-year.
- Pediatrix Medical Group, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-09-30 was $21.39M, a 25.75% decline year-over-year.
- Pediatrix Medical Group, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was $28.28M, a 7.88% decline year-over-year.
- Pediatrix Medical Group, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was $14.21M.
- Pediatrix Medical Group, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$99.07M.
- Pediatrix Medical Group, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$60.41M, a 196.55% decline from fiscal 2022.
- Pediatrix Medical Group, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $62.56M, a 42.06% decline from fiscal 2021.
- Pediatrix Medical Group, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was $107.99M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$99.07M 10-K · filed 2025-02-20 | |||||||
| 2023-12-31 | -$124.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$102.90M derived: sum of 2 quarters · filed 2025-02-20 | -$74.61M derived: sum of 3 quarters · filed 2025-02-20 | -$60.41M 10-K · filed 2025-02-20 | ||||
| 2023-09-30 | $21.39M 10-Q · filed 2023-11-02 | $49.67M derived: sum of 2 quarters · filed 2023-11-02 | $63.88M 10-Q · filed 2023-11-02 | $87.88M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $28.28M 10-Q · filed 2023-08-03 | $42.49M 10-Q · filed 2023-08-03 | $66.49M derived: sum of 3 quarters · filed 2025-02-20 | $95.30M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $14.21M 10-Q · filed 2023-05-02 | $38.21M derived: sum of 2 quarters · filed 2025-02-20 | $67.01M derived: sum of 3 quarters · filed 2025-02-20 | $97.72M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $52.81M derived: sum of 2 quarters · filed 2025-02-20 | $83.51M derived: sum of 3 quarters · filed 2025-02-20 | $62.56M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $28.81M 10-Q · filed 2023-11-02 | $59.51M derived: sum of 2 quarters · filed 2023-11-02 | $38.56M 10-Q · filed 2023-11-02 | $78.84M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | $30.70M 10-Q · filed 2023-08-03 | $9.76M 10-Q · filed 2023-08-03 | $50.03M derived: sum of 3 quarters · filed 2024-02-20 | $81.87M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | -$20.95M 10-Q · filed 2023-05-02 | $19.33M derived: sum of 2 quarters · filed 2024-02-20 | $51.17M derived: sum of 3 quarters · filed 2024-02-20 | $81.70M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | $40.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $72.12M derived: sum of 2 quarters · filed 2024-02-20 | $102.64M derived: sum of 3 quarters · filed 2024-02-20 | $107.99M 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | $31.84M 10-Q · filed 2022-11-03 | $62.37M derived: sum of 2 quarters · filed 2022-11-03 | $67.71M 10-Q · filed 2022-11-03 | $72.20M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $30.53M 10-Q · filed 2022-08-04 | $35.87M 10-Q · filed 2022-08-04 | $40.36M derived: sum of 3 quarters · filed 2022-08-04 | $37.71M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $5.34M 10-Q · filed 2022-04-28 | $9.83M derived: sum of 2 quarters · filed 2022-04-28 | $7.18M derived: sum of 3 quarters · filed 2022-04-28 | $14.26M derived: sum of 4 quarters · filed 2022-04-28 | ||||
| 2020-12-31 | $4.49M 10-K · filed 2021-02-18 | $1.83M derived: sum of 2 quarters · filed 2021-10-28 | $8.92M derived: sum of 3 quarters · filed 2021-10-28 | -$9.58M 10-K · filed 2023-02-17 | ||||
| 2020-09-30 | -$2.65M 10-Q · filed 2021-10-28 | $4.43M derived: sum of 2 quarters · filed 2021-10-28 | -$14.07M 10-Q · filed 2021-10-28 | -$4.14M derived: sum of 4 quarters · filed 2021-10-28 | ||||
| 2020-06-30 | $7.08M 10-Q · filed 2021-08-06 | $7.60M 10-Q · filed 2020-07-30 | -$11.41M 10-Q · filed 2021-08-06 | -$6.15M 10-Q · filed 2020-07-30 | -$1.49M derived: sum of 3 quarters · filed 2021-08-06 | $11.40M derived: sum of 4 quarters · filed 2021-08-06 | ||
| 2020-03-31 | -$18.50M 10-Q · filed 2021-05-07 | -$16.11M 10-Q · filed 2020-05-07 | -$8.57M derived: sum of 2 quarters · filed 2021-05-07 | $4.32M derived: sum of 3 quarters · filed 2021-05-07 | $10.84M derived: sum of 4 quarters · filed 2021-05-07 | |||
| 2019-12-31 | $9.93M 10-K · filed 2021-02-18 | $32.98M 10-K · filed 2020-02-20 | $22.81M derived: sum of 2 quarters · filed 2021-02-18 | $29.34M derived: sum of 3 quarters · filed 2021-02-18 | $42.21M 10-K · filed 2022-02-17 | -$1.15B 10-K · filed 2020-02-20 | ||
| 2019-09-30 | $12.89M 10-K · filed 2021-02-18 | -$1.26B 10-Q · filed 2019-11-01 | $19.41M derived: sum of 2 quarters · filed 2021-02-18 | $32.28M 10-Q · filed 2020-11-06 | -$1.18B 10-Q · filed 2019-11-01 | $93.94M derived: sum of 4 quarters · filed 2021-02-18 | ||
| 2019-06-30 | $6.53M 10-K · filed 2021-02-18 | $35.52M 10-Q · filed 2019-08-01 | $42.59M 10-Q · filed 2020-07-30 | $77.17M 10-Q · filed 2019-08-01 | $81.06M derived: sum of 3 quarters · filed 2021-02-18 | $143.22M derived: sum of 4 quarters · filed 2021-02-18 | ||
| 2019-03-31 | $12.87M 10-K · filed 2021-02-18 | $41.65M 10-Q · filed 2019-05-02 | $74.53M derived: sum of 2 quarters · filed 2021-02-18 | $136.70M derived: sum of 3 quarters · filed 2021-02-18 | $211.47M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2018-12-31 | $61.66M 10-K · filed 2020-02-20 | $123.83M derived: sum of 2 quarters · filed 2020-02-20 | $198.60M derived: sum of 3 quarters · filed 2020-02-20 | $121.51M 10-K · filed 2021-02-18 | $258.61M 10-K · filed 2020-02-20 | |||
| 2018-09-30 | $62.17M 10-K · filed 2020-02-20 | $136.94M derived: sum of 2 quarters · filed 2020-02-20 | $196.95M 10-Q · filed 2019-11-01 | |||||
| 2018-06-30 | $74.78M 10-K · filed 2020-02-20 | $134.78M 10-Q · filed 2019-08-01 | ||||||
| 2018-03-31 | $60.01M 10-K · filed 2020-02-20 | |||||||
| 2017-12-31 | $305.44M 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |